Latest filing published 31 Mar 2023 for 9 METERS BIOPHARMA, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Mark A. Sirgo, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in 9 Meters Biopharma, Inc. and Biodelivery Sciences International Inc. The record holds 18 filings, for trades running from 11 May 2021 to 29 March 2023.
Both buying and selling appear: 11 purchases worth €435k, against 1 sale worth €27k. The net balance comes to €408k on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants and 3 option exercises.
Half of the purchases are above €41k and half below. 9 out of 10 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.
On 31 March 2023 came the latest disclosure, a share grant in 9 Meters Biopharma, Inc. The clock since the last published purchase (6 July 2022) now reads 1,565 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations